rs368706722
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_000257.4(MYH7):c.5562G>A(p.Thr1854=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,612,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00018 ( 0 hom. )
Consequence
MYH7
NM_000257.4 splice_region, synonymous
NM_000257.4 splice_region, synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.24
Genes affected
MYH7 (HGNC:7577): (myosin heavy chain 7) Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing distal myopathy. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
?
Variant 14-23414100-C-T is Benign according to our data. Variant chr14-23414100-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 43075.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-23414100-C-T is described in Lovd as [Benign].
BP7
?
Synonymous conserved (PhyloP=-3.24 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.5562G>A | p.Thr1854= | splice_region_variant, synonymous_variant | 38/40 | ENST00000355349.4 | |
MYH7 | NM_001407004.1 | c.5562G>A | p.Thr1854= | splice_region_variant, synonymous_variant | 37/39 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.5562G>A | p.Thr1854= | splice_region_variant, synonymous_variant | 38/40 | 1 | NM_000257.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000151 AC: 23AN: 152164Hom.: 0 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
23
AN:
152164
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000116 AC: 29AN: 249876Hom.: 0 AF XY: 0.000141 AC XY: 19AN XY: 135202
GnomAD3 exomes
AF:
AC:
29
AN:
249876
Hom.:
AF XY:
AC XY:
19
AN XY:
135202
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000175 AC: 256AN: 1459934Hom.: 0 Cov.: 33 AF XY: 0.000193 AC XY: 140AN XY: 726376
GnomAD4 exome
AF:
AC:
256
AN:
1459934
Hom.:
Cov.:
33
AF XY:
AC XY:
140
AN XY:
726376
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000151 AC: 23AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74458
GnomAD4 genome
?
AF:
AC:
23
AN:
152282
Hom.:
Cov.:
33
AF XY:
AC XY:
15
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 02, 2012 | p.Thr1854Thr in exon 38 of MYH7: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 2/8600 European A merican chromosomes from a broad population by the NHLBI Exome Sequencing Projec t (http://evs.gs.washington.edu/EVS). - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 27, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jun 12, 2017 | p.Thr1854Thr (c.5562G>A (silent); chr14:23883309 ) in the MYH7 gene (NM_000257.3) Given that there are no strong case reports available for this variant and that this variant is present at a high frequency in the general population, we consider this variant a variant of uncertain significance, likely benign and we do not feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). This variant is present in ClinVar and is classified as a variant of uncertain significance by one lab, a likely benign variant by two labs and a benign variant by the final lab. This variant may have been reported in the literature, although it is unclear. This is a weak case, as the paper states that two variants were found in 2 individuals with HCM: MYBPC3 IVS14-23G>A in combination with "MYH7 T1854 mol/L." I am unclear if the mol/L is a typo. It is not mentioned again in the paper. It is classified as a disease-causing mutation based on in silico analysis (Page et al 2012). This residue is not enriched in cases vs controls (Homburger et al 2016, amr et al 2016). Per the test report, "Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies." The threonine at codon 1854 is moderately conserved across species, whereas neighboring amino acids are strongly conserved. Another variant at this codon (p.Thr8154Met) is classified as follows in Clinvar (#= number of labs): pathogenic (1) likely pathogenic (1) and as a VUS (2). A nearby variant (p.Glu1856Lys), is reported to be pathogenic for Liang distal myopathy type 1; however, it has not been classified by any clinical labs. The variant was reported online in 34 of 137,831 individuals in the Genome Aggregation Consortium Dataset (gnomAD; http://gnomad.broadinstitute.org/), which currently includes variant calls on >140,000 unrelated individuals of African, Asian, European, Ashkenazi, Latino descent. Specifically, the variant was observed in 31 of 63,301 individuals of European descent (MAF=0.02%), 3 of 17,206 individuals of Latino descent. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. - |
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Aug 25, 2018 | - - |
MYH7-related condition Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 08, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Primary dilated cardiomyopathy Benign:1
Likely benign, no assertion criteria provided | clinical testing | Blueprint Genetics | Sep 29, 2014 | - - |
Hypertrophic cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at